Company Filing History:
Years Active: 2009-2013
Title: Kuljit Singh Bhatia: Innovator in Transdermal Drug Delivery
Introduction
Kuljit Singh Bhatia is a notable inventor based in Scottsdale, AZ, recognized for his contributions to the field of transdermal drug delivery systems. With two patents to his name, Bhatia has made significant advancements in the formulation of fentanyl-based silicone adhesives, enhancing the efficacy of drug delivery.
Latest Patents
Kuljit Singh Bhatia's latest patents focus on "Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl." These innovative formulations involve suspending fentanyl particles in one or more solvated silicone adhesives. The resultant formulations pave the way for the manufacturing of improved, matrix-type transdermal devices used to administer fentanyl effectively.
Career Highlights
Bhatia works at Mylan Pharmaceuticals Inc., a leading company in the pharmaceutical industry. His role involves researching and developing advanced drug delivery systems that are crucial for patient care and safety. His patented technologies reflect his dedication to improving healthcare through innovation.
Collaborations
Throughout his career, Kuljit Singh Bhatia has collaborated with notable colleagues, including Kenneth James Miller II and Sharad K Govil. These collaborations have been instrumental in pushing the boundaries of pharmaceutical research and ensuring that innovations reach the market.
Conclusion
In conclusion, Kuljit Singh Bhatia's contributions to transdermal drug delivery systems through his patents on fentanyl suspension-based silicone adhesive formulations underscore his significant role as an inventor. His work at Mylan Pharmaceuticals Inc. and collaborations with esteemed colleagues continue to impact the pharmaceutical industry positively. As he moves forward, Bhatia's innovations will likely shape the future of medication delivery methods.